Clinical Research
corporate_fare

LETI Pharma S.L.U.

Address
Calle Del Sol 5, Zona Industrial Tres Cantos

Sponsor Overview

assignment
3
sponsored trials
science
16
molecules
location_city
58
research centres
public
2
countries
person_search
91
investigators

Specializations

Allergen Immunotherapy

LETI Pharma S.L.U. focuses on subcutaneous immunotherapy for allergic rhinoconjunctivitis, with research centered on clinical responses to house dust mite and pollen allergens.

  • Dermatophagoides pteronyssinus and Dermatophagoides farinae
  • Grass pollen immunotherapy
  • Olive pollen immunotherapy

The sponsor’s trials examine treatment effects in patients with persistent nasal and ocular allergy symptoms, including those with controlled asthma.

Respiratory Allergy and Asthma

Clinical research activity includes patients with allergic rhinitis and allergic rhinoconjunctivitis, particularly when these conditions coexist with asthma.

  • Moderate to severe persistent symptoms
  • Seasonal pollen-related disease
  • Controlled asthma comorbidity

Trials are designed around symptom burden during allergen exposure periods and the management of upper and lower airway allergic disease.

Pollen-Driven Seasonal Allergy

The sponsor investigates immunotherapy for grass and olive pollen-related disease, with emphasis on seasonal symptom control and medication use during peak exposure.

  • Grass pollen sensitisation
  • Olive pollen sensitisation
  • Combined symptom and medication outcomes

Research activity reflects interest in clinically relevant sensitisation patterns that drive seasonal rhinoconjunctivitis.

House Dust Mite Allergy

LETI Pharma S.L.U. also funds studies in perennial allergy caused by house dust mite exposure, addressing ongoing symptoms outside the pollen season.

  • Dust mite extract mixtures
  • Persistent allergic rhinoconjunctivitis
  • Asthma-associated allergy

This area extends the sponsor’s interest in both indoor and outdoor allergen-driven respiratory disease.

Sponsored Trials

Trial Name Country Status
A multicenter, double-blind, placebo-controlled, clinical trial to evaluate the efficacy and safety of two concentrations of a mixture of depigmented polymerized allergenic extracts of D. pteronyssinus and D. farinae, in patients suffering from allergic rhinoconjunctivitis with or without controlled asthmaSpain SpainNot Yet Recruiting
Efficacy and Safety of Depigmented Polymerized Grass Pollen Extracts in Patients with Allergic Rhinoconjunctivitis and Controlled Asthma: A Randomized Controlled TrialPortugal PortugalSpain SpainRecruiting
Efficacy and safety of grass and olive pollen extract combination therapy versus placebo in patients with allergic rhinoconjunctivitis and asthmaPortugal PortugalSpain SpainRecruiting

Data & Insights

science
Molecule Portfolio
Compounds under investigation
1
Exclusive Molecules
out of 16 total (6% not shared with other sponsors)

This sponsor works with 16 molecules, of which 1 is not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
50%
Return partnership rate
29 of 58 sites collaborated multiple times

This sponsor has worked with 58 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Immune System Diseases3 trials
    322 other sponsors
  • 2.
    Respiratory Tract Diseases2 trials
    277 other sponsors

Partnered Research Centres

58 centres
location_city
assignment63
Althaia Xarxa Assistencial Universitaria De Manresa Fundacio Privada
Address
Carrer Del Doctor Joan Soler 1-3, 08243 Manresa
Learn morearrow_forward
location_city
assignment86
Area De Salud De Burgos Y Soria
Address
Avenida De Las Islas Baleares 3, 09006 Burgos
Learn morearrow_forward
location_city
assignment364
Bellvitge University Hospital
Address
Carrer De La Feixa Llarga S/N, 08907 L'hospitalet De Llobregat
Learn morearrow_forward
location_city
assignment146
Centro Hospitalar Universitario Sao Joao E.P.E.
Address
Alameda Professor Hernani Monteiro, 4200-319 Porto
Learn morearrow_forward
location_city
assignment5
Clínica Dermatología y Alergia
Address
Calle Muñoz Torrero, 21, 06001 Badajoz
Learn morearrow_forward
location_city
assignment138
Complejo Hospitalario Universitario Insular Materno Infantil
Address
Autovia Del Sur S/n, 35017 Las Palmas de Gran Canaria
Learn morearrow_forward
Page 1 of 10

Want to get in touch with this sponsor?

Send a question and we'll pass it on to LETI Pharma S.L.U..

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.